MTP131 is usually described in one line: a mitochondria-targeted peptide that binds cardiolipin. True, and almost useless unless you already know what cardiolipin is and why binding to it would do anything. Most of the people who write to us do not, and there is no shame in that. It is a corner of cell biology that barely gets a paragraph in most textbooks.
This article is our attempt to explain the mechanism the way we would to a new colleague over coffee. No equations. Six ideas, each building on the last. By the end you should be able to read a paper on MTP131 and follow the argument.
A note on the name: MTP131 is the same molecule as SS-31 and elamipretide. If the naming is new to you, our article on MTP-131 and its other names sorts it out.
Table of Contents
Table of Contents
Insight 1: Mitochondria make energy across a folded membrane
Start with the basics. A mitochondrion has two membranes. The outer one is a smooth bag. The inner one is heavily folded, and those folds are called cristae.
The inner membrane is where energy is made. Set into it are five large protein machines. Four of them, complexes I to IV, pass electrons down a chain and use the energy released to pump protons from the inside to the space between the membranes. That builds up a pressure of protons. The fifth machine, ATP synthase, lets the protons flow back and uses the flow to make ATP, the cell's energy currency.
Two things about this matter for our story.
The machines need to be close together and correctly lined up. Electrons have to hop from one to the next. If the complexes drift apart, electrons leak, and leaked electrons react with oxygen to form damaging reactive species.
The membrane has to be folded and sealed. The folds give more surface area and create small compartments where protons collect. If the folds flatten or the membrane gets leaky, the proton pressure falls and so does ATP output.
So the shape and organisation of the inner membrane are not decoration. They are part of how the thing works.
Insight 2: Cardiolipin is what holds that membrane together
Cardiolipin is a phospholipid, a fat molecule of the kind that makes up all cell membranes. It is an odd one. A normal phospholipid has one head and two fatty tails. Cardiolipin is essentially two of them joined at the head, so it has two phosphate groups and four tails.
That gives it three special properties.
It is cone-shaped, narrow at the head and wide at the tails. Cone-shaped lipids like to sit in curved membranes. Cardiolipin collects at the tight bends of the cristae and helps keep them bent.
It carries two negative charges. That lets it grip positively charged patches on proteins.
It is found almost nowhere except the inner mitochondrial membrane, where it makes up something like a fifth of the lipid.
Put these together and cardiolipin acts as a sort of glue and scaffold. It sits between the respiratory complexes and helps them assemble into larger units called supercomplexes. It binds to ATP synthase and helps it form the rows that shape the cristae tips. It anchors a small mobile protein called cytochrome c to the membrane surface so it can shuttle electrons between complex III and complex IV.
When cardiolipin is missing or abnormal, as in the genetic disease Barth syndrome, all of this falls apart to some degree. Cristae lose their shape. Supercomplexes come apart. Energy output drops.
Insight 3: Cardiolipin is easily damaged, and the damage feeds on itself
Here is the weak point. In heart and muscle, the four tails of cardiolipin are mostly linoleic acid, an unsaturated fat. Unsaturated fats are prone to oxidation. And cardiolipin sits right beside the electron transport chain, which is the main source of reactive oxygen species in the cell.
So the lipid that holds the energy machinery together is parked next to the thing most likely to damage it.
When cardiolipin is oxidised, it changes shape and no longer fits where it should. Complexes loosen. More electrons leak. More reactive species form. More cardiolipin is oxidised. It is a loop, and once it gets going it is hard to stop.
This loop is thought to turn in ageing, in tissue that has been starved of oxygen and then resupplied, in heart failure and in a range of other conditions. It is the reason cardiolipin became a target.
Insight 4: Cytochrome c has a dark side
This is the part of the story that surprised people. Cytochrome c is normally a well-behaved electron carrier. It sits loosely on the membrane surface, held by the charge on cardiolipin, and ferries electrons one at a time.
But cytochrome c can bind cardiolipin in a second, tighter way, in which one of the lipid's tails pushes into the protein. When that happens, the protein partly unfolds around its iron-containing core. In that state it stops being a carrier and becomes a peroxidase, an enzyme that uses hydrogen peroxide to oxidise things. And the thing nearest to hand is cardiolipin itself.
So under stress, cytochrome c turns on the very lipid that holds it in place. The oxidised cardiolipin lets go. Cytochrome c drifts off into the space between the membranes, and if the outer membrane becomes leaky, out into the cell, where it triggers programmed cell death.
That sequence, cardiolipin oxidation followed by cytochrome c release, is one of the early steps in apoptosis. It links a small change in a membrane lipid to the death of the whole cell.
Insight 5: What MTP131 does at the membrane
Now MTP131. MTP131 has four amino acids arranged as charged, aromatic, charged, aromatic, with three positive charges in total. We go through the structure in our article on elamipretide peptide chemistry.
Those positive charges are drawn to the negative charges on cardiolipin. The aromatic rings tuck into the oily part of the membrane just below the surface. The result is that MTP131 sits at the interface, lying along the membrane, in close contact with cardiolipin head groups.
A paper in 2013 showed this binding directly using fluorescent versions of MTP131 and went on to show what it does. Three effects are worth knowing.
It blocks the peroxidase switch
With MTP131 bound to cardiolipin, cytochrome c is less able to make the tight, tail-inserting contact that unfolds it. It stays in carrier mode. In the test tube, MTP131 strongly reduced the peroxidase activity of the cytochrome c and cardiolipin complex. That would break the loop described above at its key step.
It keeps electrons flowing
By holding cytochrome c in its normal state, and possibly by tidying the lipid environment around the complexes, MTP131 improved electron transfer and ATP production in mitochondria that had been stressed. In healthy mitochondria it did very little. That selectivity for stressed mitochondria comes up again and again in the literature.
It protects cristae structure
In animal models of kidney and heart injury, electron microscope images showed that mitochondria in treated tissue kept their folded inner membranes, while those in untreated tissue were swollen with broken cristae.
Insight 6: The picture has grown more detailed since
If the story stopped in 2013 it would be neat. It did not stop, and the newer work makes it richer and a bit less tidy.
One line of research looked at the electrical properties of the membrane surface. Cardiolipin makes the surface strongly negative, which attracts calcium and other positive ions. Too much calcium at the membrane is harmful. Studies published around 2020 showed that MTP131 tones down that surface charge and reduces the membrane's response to calcium, without disrupting the membrane itself. On this view MTP131 works partly as an electrostatic buffer.
Another study used chemical cross-linking in intact mitochondria to find out which proteins MTP131 sits next to. It found a dozen, falling into two groups: proteins involved directly in making ATP, and proteins involved in a branch of metabolism that feeds the electron transport chain. All of them are known to bind cardiolipin. That suggests MTP131 ends up at protein and cardiolipin contact points across the membrane.
Work in aged heart cells pointed to a specific protein, the adenine nucleotide translocator, which swaps ATP for ADP across the inner membrane. In old cells this protein leaks protons. MTP131 reduced that leak.
And the original antioxidant idea has not gone away. The dimethyltyrosine residue does scavenge reactive species directly. Most researchers now see that as a secondary contribution, but it is real.
So the honest summary is this. MTP131 binds cardiolipin. That much is well established. What follows from the binding is probably several things at once, and which matters most likely depends on the tissue and the kind of stress.
What this means if you are designing an experiment
Mechanism is only useful if it changes what you do at the bench. A few thoughts.
Stress your system
MTP131 does little in healthy mitochondria. If your cells are happy, well fed and unstressed, you may see nothing. Most positive studies used some kind of challenge: oxygen deprivation and return, oxidative stress, high glucose, ageing, a genetic defect.
Measure structure as well as function
Given that the proposed mechanism is about membrane organisation, readouts such as cristae shape on electron microscopy, supercomplex assembly on native gels or cardiolipin oxidation by mass spectrometry are directly relevant. Oxygen consumption alone may not tell the whole story.
Use the right control
SS-20 is a sister peptide without the dimethyltyrosine. It reaches mitochondria but lacks the radical-scavenging group, so it helps separate antioxidant effects from the rest. We describe it in our guide to the Szeto-Schiller peptide family.
Give it time
Binding is fast, minutes. Rebuilding membrane structure and letting cells recover is slower. Some of the most striking results in animals and in patients appeared only after weeks or months.
There is more on choosing models in our piece on Szeto Schiller 31 research models.
How MTP131 differs from other mitochondrial compounds
People often ask how this compares with MitoQ or SkQ1. Those are antioxidants attached to a positively charged carrier that is pulled into mitochondria by the membrane potential. They accumulate in the matrix, and they need a healthy membrane potential to get there.
MTP131 is different on both counts. Its uptake depends much less on membrane potential, so it still reaches depolarised, damaged mitochondria. And it stays at the inner membrane where cardiolipin is, not in the matrix.
Neither approach is better in the abstract. They do different things. But if your interest is the inner membrane and cardiolipin specifically, this is the more direct tool.
It also has nothing in common mechanistically with the other peptides we carry. BPC-157, TB-500, GHK-Cu and Retatrutide act through entirely separate pathways.
The link to Barth syndrome
It is worth closing the loop on the clinical side, because it is the best real-world test of the mechanism so far.
Barth syndrome is caused by loss of the enzyme that gives cardiolipin its mature set of tails. Patients have less normal cardiolipin and an abnormal intermediate form. Their mitochondria are structurally disorganised.
If MTP131 truly works by stabilising cardiolipin-dependent structure, this is where it should help most. After a long and difficult development, a pharmaceutical form was granted accelerated approval for Barth syndrome in the United States in 2025. We tell that story in our article on elamipretide.
That product is a prescription medicine. The material we sell is a research chemical for laboratory use only and is not for human or animal consumption.
Getting MTP131 for your lab
We list MTP131 as SS-31, in four purity grades.
- Standard Grade, 98 percent or better, for pilots and method work.
- High Purity Grade, for routine cell culture.
- Ultra-Pure Research Grade, 99.5 percent or better, with HPLC and mass spec.
- Bulk Research Grade, for labs running isolated mitochondria or tissue work at volume.
For mechanism studies where you may be making claims about a specific molecular interaction, we would lean toward the Ultra-Pure grade, since a reviewer may ask about impurities. For screening conditions, Standard is enough.
The minimum order is 50 units. Press Order beside any size on the SS-31 peptide page, add your quantity and delivery address, and we will reply by email with the total, usually the same day. Payment is by Apple Pay, Zelle, Chime, Cash App, USDT or Bitcoin. A Certificate of Analysis ships with every order, and you can ask to see it first through the contact page.
A way to picture it
If the detail above is hard to hold in your head, try this picture. It is not exact, but it is close enough to be useful.
Think of the inner membrane as a factory floor that has been folded up to fit more machines in. The machines are the respiratory complexes. They have to stand in a line, close together, so that parts can be passed from one to the next without being dropped.
Cardiolipin is the set of floor brackets that bolts each machine in place and keeps the floor folded. Take the brackets away, or let them rust, and the machines start to shift. Parts get dropped. Dropped parts are the leaked electrons, and they cause fires.
Cytochrome c is a worker who carries parts between two of the machines. Normally he holds on to a bracket lightly as he goes back and forth. Under bad conditions he grabs it too hard, changes his behaviour, and starts taking a hammer to the brackets instead.
MTP131 is a clip that fits over the bracket. With the clip on, the bracket is harder to damage, the worker cannot grab it the wrong way, and the machines stay where they should.
The picture breaks down if you push it. Lipids move, proteins breathe, and nothing in a membrane is bolted to anything. But as a first sketch of why a small peptide sitting on a lipid could affect energy output, it does the job.
Common misunderstandings about MTP131
We hear a handful of wrong ideas often enough to list them.
That it boosts healthy mitochondria. The evidence says otherwise. In study after study, MTP131 had little or no effect on mitochondria that were working normally. It appears to restore, not to enhance.
That it is just another antioxidant. If that were all, ordinary antioxidants would do the same job, and in most of the models tested they do not. The location and the lipid binding are what set it apart.
That it enters the mitochondrial matrix. It concentrates at the inner membrane. That is where cardiolipin is and where MTP131 stays.
That it replaces cardiolipin. It does not add lipid or repair the lipid chemically. It binds to what is there and changes how that lipid interacts with its neighbours.
That more is always better. Because binding is to a limited number of sites, there is no reason to expect ever-rising effects with ever-rising concentration. Several cell studies report a plateau, and a few report a bell shape. Run a range.
That it works instantly in every model. Uptake is fast. Functional recovery can take much longer, particularly where structure has to be rebuilt.
What is still not known
It would be wrong to give the impression that the mechanism is finished business. Some of the open questions:
How much of the effect comes from each of the proposed actions? Blocking cytochrome c peroxidase activity, tuning the surface charge, stabilising protein and lipid contacts and scavenging radicals have all been shown in one system or another. Nobody has cleanly separated them in a living tissue.
Does MTP131 bind other negatively charged lipids to a meaningful degree in cells? In model membranes it prefers cardiolipin, but real membranes are more complicated.
Why do some tissues respond more than others? Cardiolipin content and composition differ between heart, muscle, kidney and brain. That may be part of the answer.
What happens over months? Most mechanistic work looks at minutes to days. The clinical experience suggests the important changes may be slower.
These are good questions to be working on. The tools are available: cardiolipin lipidomics, native gels for supercomplexes, cryo-electron tomography for cristae, cross-linking mass spectrometry for neighbours. And MTP131 itself is simple to obtain and to handle, which is not true of many mechanistic probes.
Where to go from here
If this is your first reading on the subject, the next step is a primary paper. Pick the 2013 study that first showed MTP131 binding cardiolipin, read the figures before the text, and see whether the argument above matches what the data show. Then decide what you would measure in your own system.
Questions about MTP131 and cardiolipin
Does MTP131 bind anything other than cardiolipin?
It has the strongest affinity for cardiolipin among the membrane lipids tested, because of the double negative charge. Cross-linking studies show it close to several cardiolipin-binding proteins, which is likely a consequence of where it sits.
Is MTP131 an antioxidant?
Partly. It can scavenge reactive species through its dimethyltyrosine. Its main effect is now thought to be on membrane and protein organisation.
Why does it do so little in healthy cells?
Probably because in healthy mitochondria cardiolipin is intact and correctly placed, so there is little for MTP131 to rescue.
How quickly does MTP131 get into mitochondria?
Within minutes in cultured cells, according to the early uptake studies.
Where can I read the primary papers?
Search PubMed for SS-31 and cardiolipin. The 2013 and 2020 papers are the ones to start with.
In brief
The inner mitochondrial membrane has to be folded and organised to make energy. Cardiolipin keeps it that way and is easily damaged. Damaged cardiolipin turns cytochrome c into an enzyme that damages it further. MTP131 binds cardiolipin, interrupts that loop and helps the membrane hold its structure under stress.
That is the mechanism in six steps. For storage and handling once the vials arrive, see our SS-31 peptide storage guide.